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Abstract
Background: Various cytokines and other compounds are produced in human adipose tissue and
might have functions in the adipose tissue. They might be involved in complications associated with
obesity and diabetes. Recently, interleukin-8 (IL-8) has been shown to be produced and released
from human adipose tissue and/or adipocytes, suggesting IL-8 involvement in some obesity-related
health complications. Therefore, we found it of interest to investigate whether IL-8 is involved in
the insulin action in human adipocytes.
Methods: The IL-8 levels in the medium were measured using ELISA. The IL-8 mRNA expression
was analyzed using Northern blot analysis. The phosphorylation of Akt was analyzed using Western
blot analysis. Furthermore, we examined the effect of IL-8 on the phosphorylation of Akt induced
by insulin.
Results: The level of IL-8 in the medium and the IL-8 mRNA expression after stimulation with
either TNF-α, IL-1β, or CRP was significantly enhanced in human adipocytes. It is particularly
interesting that IL-8 per se also enhanced IL-8 mRNA expression. The IL-8 induced-IL-8 mRNA
expression was inhibited by PD98059 (a MEK inhibitor) or SB203580 (a p38 MAPK inhibitor). The
IL-8 inhibited insulin-induced Akt phosphorylation. The inhibitory effect of IL-8 was eliminated by
either PD 98059 or SB203580.
Conclusion: These data suggest that IL-8 is a main adipocytokine producing insulin resistance via
the inhibition of insulin-induced Akt phosphorylation in adipocytes. The attenuation of IL-8 action
might be a target for prevention of diabetes and its complications.
Background
Insulin resistance is defined as the impaired ability of tar-
get tissues of fat, liver, and muscle to show various meta-
bolic effects of insulin, including glucose uptake [1]. It is
probably caused by defects in the insulin signal transduc-
tion pathways [2,3]. Insulin resistance is central to the
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pathophysiology of metabolic syndrome because it is
associated with type 2 diabetes, hypertension, and dyslip-
idemia. In that state, the risk for cardiovascular diseases is
increased [4]. Although the molecular mechanisms lead-
ing to development of insulin resistance are not fully
understood, an association appears to exist between insu-
lin resistance and the accumulation of abdominal visceral
fat.
Adipocytes synthesize and secrete a variety of bioactive
proteins in addition to their role in fat storage. During the
development of obesity and type 2 diabetes these cells
increase in size and number and their metabolic activity is
dramatically altered. It is conceivable that some adi-
pocyte-derived factors underlie the association of insulin
resistance and increased risk for coronary heart disease
[5]. Tumor necrosis factor-α (TNF-α) is also elevated in
obesity and may contribute to many aspects of adipose tis-
sue biology including development of insulin resistance
and abnormalities in lipid metabolism. Hotamisligil et al.
have reported that TNF-α inhibits the phosphorylation of
Akt by insulin [6]. Insulin action is the consequence of
insulin binding to its plasma membrane receptor and is
transmitted through the cell by a series of protein-protein
interactions such as insulin receptor substrates 1 and 2
(IRS-1 and IRS-2), phosphatidyl- inositol-3 (PI3)-kinase,
and protein kinase (PK) B/Akt. Activation of PKB/Akt is a
key step for initiating several of insulin's metabolic effects,
including glucose uptake and GLUT-4 translocation [7,8].
Hill et al. reported that microinjection of a PKB/Akt sub-
strate peptide or an antibody to PKB/Akt inhibited the
effect of insulin-stimulated GLUT-4 translocation in adi-
pocytes [9]. Therefore, it is conceivable that inhibition of
insulin-induced Akt activation is reflected in insulin resist-
ant states. Hauner et al. also have reported that TNF-α
down-regulates the insulin-sensitive glucose transporter
GLUT-4, consequently decreasing glucose uptake in adi-
pocytes [10].
Recently, it was reported that TNF-α stimulates the IL-8
production in human adipocytes [11]. In fact, IL-8, a
chemokines, is known to activate neutrophils. However,
little evidence is available to describe the role of IL-8 in
adipocytes, obesity, and the development of insulin resist-
ance.
In the present study, we show that the IL-8 production in
human adipocytes is enhanced by inflammatory sub-
stances such as TNF-α, IL-1β, and CRP, and we examined
the effect of IL-8 on insulin-induced Akt phosphorylation
in adipocytes.
Methods
Cell culture
Human adipocyte culture. Cryopreserved human subcuta-
neous preadipocytes derived from human adipose tissue
were obtained (together with culture media) from Cam-
brex Bio Science, Walkersville, Inc. The cells were cultured
with preadipocyte growth medium (PGM) containing
10% FCS, 2 mM L-glutamine, 100 units/ml penicillin and
100 μg/ml streptomycin to reach confluence. Then, cells
were differentiated into mature adipocytes by incubation
with adipocyte differentiation medium containing 10 μg/
ml insulin, 1 μM dexamethasone, 200 μM indomethacin
and 500 μM isobutylmethylxanthine.
Measurement of IL-8 in the media
Mature adipocytes were stimulated using either TNF-α, IL-
1β, or CRP for 18 h. For measurement of IL-8 release from
adipocytes in the medium, the media were collected. Then
the concentrations of IL-8 in the media were measured by
enzyme linked immunosorbent assay (ELISA) [12].
Northern blot analysis
Northern blot analysis was performed according to the
method described previously [13]. Briefly, mature adi-
pocytes were stimulated by either TNF-α, IL-1β, CRP, or
IL-8 for 18 h. Then RNA from the adipocytes was extracted
using ISOGEN (Nippon Gene, Japan). A digoxigenin-
labeled probe for human IL-8 cDNA with dUTP by the
random priming method (Roche Diagnostics Co.) was
used for hybridization. The intensity of the bands was
analyzed using NIH image.
Western blot analysis
The phosphorylation of Akt (Thr 308) was analysed by a
non-radioactive method using a commercial kit (New
England Biolabs Inc. and Cell Signaling). Briefly, after pre-
treatment of mature adipocytes with IL-8 for the indicated
period, cells were stimulated with insulin for 10 min.
Then, cell lysates were prepared using lysis buffer. The cell
lysates were loaded on sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis (PAGE), transferred
onto a membrane (Millipore). The following antibodies
were used: phospho-specific Akt (Thr308) antibody, Akt
antibody (Cell Signaling), and an anti-rabbit secondary
antibody conjugated to horseradish peroxidase (Amer-
sham). The intensity of the bands was analysed by NIH
image.
Data analysis
Data are presented as the mean ± s.d. Statistical analyses
were performed using ANOVA, followed by Scheffe's t-
test. A value of P < 0.05 was considered significant.
Results
First, we examined the IL-8 release in the media using
TNF-α, IL-1β, or CRP in human adipocytes. The IL-8
release in the media was increased in a time-dependentJournal of Inflammation 2009, 6:25 http://www.journal-inflammation.com/content/6/1/25
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IL-8 mRNA expression induced by IL-8 in human adipocytes Figure 1
IL-8 mRNA expression induced by IL-8 in human adipocytes. Human adipocytes were stimulated with IL-8 (50 nM or 
100 nM) for 18 h (A). The IL-8 mRNA expression was analyzed by Northern blot. For the experiments with inhibitors (B), 
0.1% DMSO was added as vehicle control, and PD98059 (50 μM) or SB203580 (50 μM) was added 2 h before stimulation with 
IL-8 (100 nM). The intensity of the IL-8 mRNA band was corrected with that of the 18s rRNA band. The data are representa-
tive of three different experiments (Means ± SD). * p < 0.01 vs. control # p < 0.05 vs. IL-8 50 nM.




Journal of Inflammation 2009, 6:25 http://www.journal-inflammation.com/content/6/1/25
Page 4 of 6
(page number not for citation purposes)
Effect of IL-8 on phosphorylation of Akt in human adipocytes Figure 2
Effect of IL-8 on phosphorylation of Akt in human adipocytes. After treatment with IL-8 (100 nM) for the indicated 
period (A), human adipocytes were stimulated with insulin (100 nM) for 10 min. The phosphorylation of Akt induced by insulin 
(100 nM) was analyzed by Western blot. For the experiments with inhibitors (B), 0.1% DMSO was added as vehicle control, 
and PD98059 (50 μM) or SB203580 (50 μM) was added 2 h before stimulation with insulin (100 nM). The data are representa-
tive of three different experiments (Means ± SD). * P < 0.01, ** P < 0.05


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manner in all stimulators, although it was less by CRP
than by TNF-α and IL-1β (data not shown). The IL-8
mRNA expression was clearly enhanced by either TNF-α,
IL-1β, or CRP (data not shown). It is particularly interest-
ing that, as presented in Fig. 1A, IL-8 per se also enhanced
the IL-8 mRNA expression in human adipocytes. Those
data suggest that inflammatory substances act on adi-
pocytes to stimulate IL-8 production in humans. Fig. 1B
shows that the IL-8 mRNA expression in human adi-
pocytes by IL-8 was inhibited by PD98059 (a MEK inhib-
itor) or SB203580 (a p38 MAPK inhibitor). The IL-8 per se
also activated the phosphorylation of ERK and p38 MAPK
(data not shown).
Next, we examined the effect of IL-8 on the action of insu-
lin in human adipocytes. Fig. 2A shows that the phospho-
rylation of Akt by insulin was diminished through
pretreatment with IL-8 in a time-dependent manner. Fig.
2B shows that the inhibitory effect of IL-8 on Akt phos-
phorylation by insulin was eliminated by either PD 98059
or SB203580. Those data suggest that IL-8 inhibits the
insulin signal pathway via the ERK pathway and p38 MAP
kinase pathway.
Discussion
In the present study, we demonstrate for the first time that
IL-8 per se enhanced the IL-8 mRNA expression in human
adipocytes and show that IL-8 has an inhibitory effect on
the Akt phosphorylation induced by insulin.
Actually, IL-8 is a monomeric polypeptide and a well-
studied member of the CXC chemokine family, which
plays a crucial role in the recruitment of neutrophils and
lymphocytes into tissues [14]. In fact, IL-8 is produced by
a variety of cells including human adipocytes [11], fre-
quently in response to inflammatory stimuli such as IL-1,
or TNF-α [14]. Here, we also observed that TNF-α, IL-1β,
and CRP enhanced IL-8 production in human adipocytes.
It is particularly interesting that IL-8 per se also enhanced
the IL-8 mRNA expression in human adipocytes. Recently,
adipocytes have been reported to express the main recep-
tor for IL-8, CXCR 1, and CXCR 2 [11]. We observed that
PD98059 or SB203580 inhibited the IL-8 induced IL-8
mRNA expression. Taken together, our data suggest that
inflammatory stimulations may create a vicious circle of
IL-8 production in human adipocytes via ERK pathway
and/or p38 MAPK pathway.
In the initiation and maintenance of inflammatory reac-
tions in the adipose tissue, IL-8 plays an important role in
the recruitment of neutrophils, lymphocytes, and mono-
cytes. However, the biological/pathological role of IL-8
expression in adipocytes and adipose tissue is not fully
understood [14]. We inferred that IL-8 itself might affect
insulin sensitivity in adipocytes. To test that possibility,
we examined the effect of IL-8 on the insulin-induced Akt
phosphorylation in fully differentiated human adi-
pocytes. Here, we observed that the insulin-induced Akt
phosphorylation was clearly diminished by IL-8; it was
abrogated by PD98059 or SB203580. Harmon et al.
reported that PD98059 does not affect the activation of
Akt induced by insulin [15]. Hernandez et al. have sug-
gested that ERK and p38 MAPK could be major factors in
TNF-α-induced insulin resistance in brown adipocytes
[16]. Those findings indicate that ERK pathway might not
be necessary for insulin-induced Akt phosphorylation,
but might be an important pathway for inhibition of
inflammatory cytokine for insulin-induced Akt phospho-
rylation. Our data also suggest that IL-8 might promote
insulin resistance in human differentiated adipocytes in
the situation of exposure to IL-8 via the ERK pathway and/
or p38 MAPK pathway. Taken together, these findings
support the notion that IL-8 might have important roles
in adipocyte physiology other than inflammatory cell
recruitment.
In conclusion, our data suggest that IL-8 is a main adi-
pocytokine producing insulin resistance via the inhibition
of insulin-induced Akt phosphorylation in human adi-
pocytes, and the attenuation of IL-8 production and/or
action may be a target for the prevention of diabetes and
its complications.
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